Gilbert, M. R., Yuan, Y., Wu, J., Mendoza, T., Vera, E., Omuro, A., . . . Armstrong, T. S. (2020). A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma. Neuro Oncol.
Chicago Style CitationGilbert, Mark R., et al. "A Phase II Study of Dose-dense Temozolomide and Lapatinib for Recurrent Low-grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma." Neuro Oncol 2020.
Cita MLAGilbert, Mark R., et al. "A Phase II Study of Dose-dense Temozolomide and Lapatinib for Recurrent Low-grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma." Neuro Oncol 2020.
Atenció: Aquestes cites poden no estar 100% correctes.